Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Top Cited Papers
Open Access
- 15 January 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (2), 785-789
- https://doi.org/10.1182/blood-2007-08-108357
Abstract
We hypothesized that increased monoclonal free kappa or lambda immunoglobulin light chains in smoldering multiple myeloma (SMM), as detected by the serum free lKeywords
This publication has 30 references indexed in Scilit:
- Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple MyelomaNew England Journal of Medicine, 2007
- Immunoglobulin free light chains and solitary plasmacytoma of boneBlood, 2006
- Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationBlood, 2006
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- Prognostic factors in low tumour mass asymptomatic multiple myeloma: A report on 91 patientsAmerican Journal of Hematology, 1995
- Risk of disease progression in asymptomatic multiple myelomaAmerican Journal Of Medicine, 1993
- Smoldering Multiple MyelomaNew England Journal of Medicine, 1980
- Monoclonal gammopathy of undetermined significanceAmerican Journal Of Medicine, 1978
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972